Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
AmeriPath Lubbock 5.01(a) Corporation, a prominent entity in the diagnostic pathology industry, is headquartered in the United States. Founded in the early 2000s, the company has established itself as a leader in providing high-quality anatomic pathology services, primarily serving healthcare providers across the Lubbock region and beyond.
Specialising in a range of core services, including histopathology and cytopathology, AmeriPath Lubbock is recognised for its commitment to accuracy and timely results, which are crucial for effective patient care. The corporation's innovative approach and utilisation of advanced technology have positioned it as a trusted partner in the medical community. With a focus on excellence and reliability, AmeriPath Lubbock continues to achieve significant milestones, reinforcing its status as a key player in the pathology sector.
+12 vs industry average
AmeriPath Lubbock 5.01(a) Corporation’s score of 43 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
HMO Medical Centers has below-average carbon intensity
The HMO Medical Centers industry has reduced its overall emissions by 25% since 2018
No reported emissions data is available for AmeriPath Lubbock 5.01(a) Corporation yet.
AmeriPath Lubbock 5.01(a) Corporation currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The organisation is a current subsidiary of Quest Diagnostics Incorporated, which means that any relevant emissions data or climate commitments may be inherited from this parent company.
As of now, AmeriPath Lubbock 5.01(a) Corporation has not established any documented reduction targets or climate pledges. The lack of specific initiatives or commitments suggests that the corporation may still be in the early stages of developing a comprehensive climate strategy.
Given its affiliation with Quest Diagnostics, it is important to consider the broader context of emissions and climate commitments that may be applicable at the corporate family level. However, without specific data or targets from AmeriPath Lubbock 5.01(a) Corporation, it is challenging to provide a detailed overview of its carbon emissions and climate commitments.
Access structured emission data, company specific factors and auditable source documents
No climate goals have been disclosed for AmeriPath Lubbock 5.01(a) Corporation yet.
No scope 3 category breakdown has been disclosed yet.


You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more